{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:06:51Z","timestamp":1648534011394},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1007\/bf01744267","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T04:25:04Z","timestamp":1118723104000},"page":"775-779","source":"Crossref","is-referenced-by-count":2,"title":["A need to intensify drug surveillance in Germany"],"prefix":"10.1007","volume":"69","author":[{"given":"J. -F.","family":"Kapp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zentgraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sch\u00f6pf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01744267_CR1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","volume":"11","author":"C Benichou","year":"1990","unstructured":"Benichou C (1990) Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11:272\u2013276","journal-title":"J Hepatol"},{"key":"BF01744267_CR2","unstructured":"Danan G, Benichou C (1990) R\u00e9union internationale de consensus sur les d\u00e9finitions et les crit\u00e8res d'evaluation des atteintes h\u00e9patiques m\u00e9dicamenteuses (1). Abstract 36. First European Symposium of Pharmacovigilance. 12th Meeting on Pharmacovigilance, 29\u201330 October, Strasbourg"},{"key":"BF01744267_CR3","unstructured":"Faich GA (1989) Memorandum. Department of Health and Human Services Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, April PMS News Quarterly, pp 1\u20136"},{"issue":"63","key":"BF01744267_CR4","first-page":"81","volume":"150","author":"JL Fink","year":"1978","unstructured":"Fink JL, Myers MJ, Palumbo FB (1978) Use of patient medication records: a three-state study. AMJ Pharm sc Support-Public-Health 150 (63): 81\u201388","journal-title":"AMJ Pharm sc Support-Public-Health"},{"key":"BF01744267_CR5","first-page":"281","volume-title":"Grundlagen der Arzneimitteltherapie","author":"J Hasford","year":"1986","unstructured":"Hasford J (1986) Methoden zur Erfassung unerw\u00fcnschter Arzneimittelwirkungen. In: D\u00f6lle W et al. (Hrsg) Grundlagen der Arzneimitteltherapie. Bibliographisches Institut, Mannheim, S 281\u2013287"},{"issue":"Suppl 5","key":"BF01744267_CR6","first-page":"S236","volume":"15","author":"J Hasford","year":"1987","unstructured":"Hasford J, Victor N (1987) Risk-benefit analyses of drugs: fundamental considerations and requirements from the point of view of the biometrician. Problems in the assessment of the combination of trimethoprim with sulfamethoxazole. Infection 15 [Suppl 5]:S236\u2013S240","journal-title":"Infection"},{"key":"BF01744267_CR7","first-page":"12","volume":"56","author":"H Helmchen","year":"1985","unstructured":"Helmchen H, Hippius B, M\u00fcller-Oerlinghausen B, R\u00fcther E (1985) Arzneimittel\u00fcberwachung in der Psychiatric. Nervenarzt 56:12\u201318","journal-title":"Nervenarzt"},{"key":"BF01744267_CR8","first-page":"9","volume-title":"Monitoring for drug safety","author":"WHW Inman","year":"1980","unstructured":"Inman WHW (1980) The United Kingdom. In: Inman WHW (ed) Monitoring for drug safety. MTP Press, Lancaster, pp 9\u201348"},{"key":"BF01744267_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM197703032960904","volume":"296","author":"H Jick","year":"1977","unstructured":"Jick H (1977) The discovery of drug-induced illness. N Engl J Med 296:481\u2013485","journal-title":"N Engl J Med"},{"issue":"9","key":"BF01744267_CR10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.1970.03170350023005","volume":"213","author":"H Jick","year":"1970","unstructured":"Jick H, Miettinen OS, Shapiro S, Lewis GP, Siskind V, Slone D (1970) Comprehensive drug surveillance. JAMA 213 (9):1455\u20131460","journal-title":"JAMA"},{"key":"BF01744267_CR11","unstructured":"Kapp JF (1987) Vortrag: Welche Lehren hat die pharmazeutische Industrie aus dem Contergan-Ungl\u00fcck gezogen? BPI-Symposium: 25 Jahre Arzneimittelgesetz \u2014 Fortschritte der Arzneimittelsicherheit, 18. Mai 1987, Bonn"},{"key":"BF01744267_CR12","first-page":"1487","volume":"83","author":"H Kewitz","year":"1977","unstructured":"Kewitz H (1977) Erhebungen \u00fcber die Arzneimitteltherapie in der Klinik. Verh Dtsch Ges Inn Med 83:1487\u20131502","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"BF01744267_CR13","unstructured":"Kreutz G (1990) Mitteilung: The principles and practice of pharmacoepidemiology. Conference 14.\u201317. October 1990, Strassburg"},{"key":"BF01744267_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/106002808702100916","volume":"21","author":"MS Porta","year":"1987","unstructured":"Porta MS, Hartzema AG (1987) The contribution of epidemiology to the study of drugs. Drug Intell Clin Pharm 21:741\u2013746","journal-title":"Drug Intell Clin Pharm"},{"key":"BF01744267_CR15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0895-4356(90)90140-K","volume":"43","author":"NSB Rawson","year":"1990","unstructured":"Rawson NSB, Pearce GI, Inman WHW (1990) Prescriptionevent monitoring: methodology and recent progress. J ClinEpidemiol 43:509\u2013522","journal-title":"J ClinEpidemiol"},{"key":"BF01744267_CR16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.294.6565.147","volume":"294","author":"AC Rossi","year":"1987","unstructured":"Rossi AC, Hsu JP, Faich GA (1987) Ulcerogenicity of piroxicam: an analysis of spontaneous reported data. Br Med J 294:147\u2013150","journal-title":"Br Med J"},{"key":"BF01744267_CR17","first-page":"687","volume":"95","author":"PS Sch\u00f6nh\u00f6fer","year":"1989","unstructured":"Sch\u00f6nh\u00f6fer PS, Wessely-Stickel B, Schulte-Sasse H, Werner W (1989) Fl\u00e4chendeckende Erfassung schwerer, potentiell lebensbedrohlicher unerw\u00fcnschter Arzneimittelwirkungen. Verh Dtsch Ges Inn Med 95:687\u2013690","journal-title":"Verh Dtsch Ges Inn Med"},{"issue":"46","key":"BF01744267_CR18","first-page":"A3641","volume":"87","author":"E Sch\u00f6pf","year":"1990","unstructured":"Sch\u00f6pf E, St\u00fchmer A, Rzany B, Victor N, Zentgraf R, Kapp JF (1990) Toxische epidermale Nekrolyse und Stevens-Johnson-Syndrom. Epidemiologische Studie 1981 bis 1985. Dtsch Aerztebl 87 (46): A3641\u20133642","journal-title":"Dtsch Aerztebl"},{"key":"BF01744267_CR19","unstructured":"Sch\u00f6pf E, St\u00fchmer A, Rzany B, Victor N, Zentgraf R, Kapp JF (in press) Toxic epidermal necrolysis (TEN) and StevensJohnson Syndrome (SJS). An epidemiologic study conducted in West Germany. Arch Dermatol"},{"key":"BF01744267_CR20","volume-title":"Arzneiverordnungsreport '87","author":"U Schwabe","year":"1987","unstructured":"Schwabe U, Paffrath D (1987) Arzneiverordnungsreport '87. Fischer, Stuttgart New York"},{"key":"BF01744267_CR21","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/jama.1990.03440130073028","volume":"263","author":"HD Scott","year":"1990","unstructured":"Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ, Green M, Andrews LG, Faich GA (1990) Physician reporting of adverse drug reations. Results of the Rhode Island Adverse Drug Reaction Reporting Project. JAMA 263:1785\u20131788","journal-title":"JAMA"},{"key":"BF01744267_CR22","first-page":"265","volume":"29","author":"P Solal-Celigny","year":"1987","unstructured":"Solal-Celigny P, Benichou C, Boivin P, Castot A, Coulombel L, Danan G, Degos L, Evreux JC, Lagier G, Lavarenne J, Sonbri\u00e9 C, Tchernia G, Tobelem G (1987) Crit\u00e8res d'imputation d'une cytop\u00e9nie granuleuse ou plaquettaire \u00e0 un m\u00e9dicament. R\u00e9sultats de r\u00e9unions de consensus. Nouv Rev Fr Hematol 29:265\u2013270","journal-title":"Nouv Rev Fr Hematol"},{"key":"BF01744267_CR23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/bmj.286.6363.458","volume":"286","author":"GR Venning","year":"1983","unstructured":"Venning GR (1983) Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems. Br Med J 286:458\u2013460","journal-title":"Br Med J"},{"issue":"13","key":"BF01744267_CR24","first-page":"A1008","volume":"87","author":"N Victor","year":"1990","unstructured":"Victor N (1990) Nutzen-Risiko-Bewertung von Arzneimitteln. Dtsch Aerztebl 87 (13): A1008\u20131019","journal-title":"Dtsch Aerztebl"},{"key":"BF01744267_CR25","first-page":"1","volume-title":"Advances in inflammation research 6","author":"JCP Weber","year":"1984","unstructured":"Weber JCP (1984) Epidemiology of adverse reactions to nonsteroidal antiinflammatory drugs. In: Rainsford KD, Velo GP (eds) Advances in inflammation research 6, Raven Press, New York, pp 1\u20137"},{"key":"BF01744267_CR26","first-page":"851","volume":"8","author":"E Weber","year":"1979","unstructured":"Weber E, Ding R, Gundert-Remy U, Harenberg J, von Kenne H, Spohr U, Walter E, Oh KU, Seidl G, Fritz U (1979) Verordnungsmuster einer Medizinischen Universit\u00e4tsklinik. Klinikarzt 8:851\u2013854","journal-title":"Klinikarzt"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01744267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01744267\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01744267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T15:00:30Z","timestamp":1557327630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01744267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":26,"journal-issue":{"issue":"17","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["BF01744267"],"URL":"https:\/\/doi.org\/10.1007\/bf01744267","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}